Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...

This was the stock's second consecutive day of losses.

The US Food and Drug Administration (FDA) has approved Boston Scientific’s expanded instructions for use (IFU) labelling of ...

Boston Scientific has claimed a new approval from the FDA for its Farapulse pulsed field ablation system, expanding its use ...

Undeniably, Barchart’s screener for unusual stock options volume is an important tool for deciphering market sentiment, ...

Boston Scientific receives US FDA approval for expanded labelling of Farapulse PFA System: Marlborough, Massachusetts Tuesday, July 8, 2025, 11:00 Hrs [IST] Boston Scientific Corp ...

Boston Scientific announces conference call discussing second quarter 2025 results. Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and ...